Perrigo Israel Pharmaceuticals Ltd.

www.perrigo.com ; www.perrigo-pharma.co.il/About-Us

Formerly Agis

Multinational Corporation

Ceased to Operate Q3/2021

TECH VERTICALS

Life Sciences, MedTech, Pharmaceuticals, Therapeutics

General Data

Sector	Biomed
Established	2005
Number of Employees	850

DESCRIPTION

Perrigo Israel is committed to develop, manufacture, and market generic pharmaceuticals, active pharmaceutical ingredients, and novel dermatological products. The company manufactures, mainly under license, a wide range of products including cardio-vascular, antibiotics, and dermatological pharmaceuticals. Perrigo Israel invests in R&D, with particular emphasis on pharmaceuticals and API and in the development of Cosmetics products, and is involved in the development of unique Ethical topical pharmaceuticals.

TECHNOLOGY

Generic Pharmaceuticals, Active Pharmaceutical Ingredients, & Dermatological Products.

Products and Phases

Product	Phase
Xyzal	FDA Approved
A therapeutic treatment for allergy
Zantac	FDA Approved
For heartburn relief
Sleep Aid	FDA Approved
A therapeutic treatment designed for falling asleep

	TARGET MARKETS
	sick funds, hospitals, pharmacies, clinics, drugstores, food chain depts., diagnostic inst

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Perrigo Co.
3496093E-207A-E111-AC59-00155D32A403	R&D Center	Perrigo Israel Pharmaceuticals Ltd.	Perrigo Co.	Ceased

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm

REMARKS

Date	Remark
06/07/2021	Altaris Capital Partners LLC completed the acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo, for total consideration equal to $1.55 billion. Following the acquisition, Padagis Israel was re-established as a local R&D center of Padagis corporation.
01/11/2004	Perrigo acquired Agis Industries and turned it into its Israeli R&D center.

CONTACT INFO

Expand / Collapse All

Main Address: Bnei Brak, Israel

Address	29 Lehi St.
POB	31
City	Bnei Brak
Country	Israel
Zip	5120050

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Shoham, Israel

Address	1 Rakefet St.
City	Shoham
Country	Israel
Zip	8413502

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Yerucham, Israel

Address	1 Burnstein Zvi St.
City	Yerucham
Country	Israel
Zip	8050315

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Apr. 13, 2007

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe	R&D grant ($1.3m)

Last Updated:	abCDe
IVC Number:	abCDe